Cloning the viral genome has made it possible to develop this serologic assay that uses recombinant antigens to avoid nonspecific cross-reactivity and to increase the sensitivity of the HCV antibody tests. The recombinant HCV proteins used in the test kit are encoded by the genes for both structural (nucleocapsid) and non-structural proteins.